Equibles does not estimate personal net worth.
Dr. John Lewicki has spoken on 1 investor event across 1 company, most recently for Mereo BioPharma Group plc on June 2, 2026. Mereo BioPharma Group plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Mereo BioPharma Group plc includes Dr. Denise Scots-Knight (CEO and Board Member), Michael S. Wyzga (Chairman), Christine Fox (CFO) and 7 others.
“Can you discuss the breadth and maybe the depth of the analyses across age groups oi severity types fracture types and bmd responders versus non-responders yeah i'll take that so as is we have and ultragenics have announced we're now focused on pediatric patients age ages two to less than 18 so that's really the focus…”
Proxy statement
Start not stated–present
Last confirmed April 9, 2026
Biotechnology · Healthcare
